Phio Pharmaceuticals stockholders approve reverse stock split; ratio up to 1:25

Phio Pharmaceuticals Corp.

Stockholders approved reverse stock split at ratio between 1:2 and 1:25; board to set exact ratio and effective date.
Vote results: 19,728,800 For, 4,120,599 Against, 150,982 Abstain.
Special meeting held January 4, 2023; record date November 17, 2022.
Company also posted updated investor presentation on its website on January 6, 2023.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Phio Pharmaceuticals Corp. shareholders approved Approval of an amendment to the Company’s Amended and Restated Certificate of Incorporation to effect a reverse stock split at a ratio between 1-for-2 and 1-for-25 at the 2023-01-04 meeting.

Proposal: reverse split
Outcome: passed
Meeting: 2023-01-04

Exact text from the filing

The Reverse Stock Split Proposal submitted to a vote of the Company’s stockholders at the Special Meeting was approved.

View on SEC.gov

560 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Phio Pharmaceuticals Corp. filing history →

Source: SEC EDGAR

accession 0001683168-23-000098

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.